Deep Brain Stimulus Devices May Cause Loss Of Coordination In Parkinson’s Patients, FDA Warns
FDA issues warning over Deep Brain Stimulation side effects on Parkison’s disease patients.…
«
»
FDA issues warning over Deep Brain Stimulation side effects on Parkison’s disease patients.…
A new study indicates concussions can lead to a variety of long-term mental disorders.…
Nuplazid is a recently introduced medication that is used to treat hallucinations caused by Parkinson’s disease. However, side effects of Nuplazid have already been linked to an alarming number of adverse events and patient deaths, leading to serious questions about whether benefits outweigh the potential health risks and whether a Nuplazid recall may be necessary. …
A lawsuit against the FDA charges the agency with failing to respond to a petition to put more stringent warnings on some Parkinson’s disease drugs which may increase the risk of compulsive behaviors.…
An ISMP report questions the FDA conclusions that there are no new safety signals with the Parkinson’s disease psychosis drug, Nuplazid.…
A new FDA report indicates that levels of pesticide in American food is below federal levels of concerns.…
A new study links a number of antidepressants, including Celexa, Cymbalta, Lexapro and Zoloft, to an increased risk of Parkinson’s disease and other movement disorders.…
A new study warns that some antidepressants and Parkinson’s disease drugs may increase the risk of dementia with long-term use.…
The FDA has launched a new safety review of the Parkinson’s disease drug Nuplazid, FDA Commissioner Scott Gottlieb told Congress last week.…
More than 700 deaths have been linked to Nuplazid side effects, raising concerns about the safety of the Parkinson’s disease drug.…